Danielle Gabrish is the Director of Clinical Biologics at AstraZeneca and the Chair of the ISPE Women in Pharma® group for ISPE’s Chesapeake Bay Chapter. She’s also a mom, mentor, and advocate for women and Emerging Leaders.
Danielle Gabrish is the Director of Clinical Biologics at AstraZeneca and the Chair of the ISPE Women in Pharma® group for ISPE’s Chesapeake Bay Chapter. She’s also a mom, mentor, and advocate for women and Emerging Leaders.
Shanghai ISPE Pharmaceutical Information Company (SPIC) held the 2023 Global Biopharma Engineering Forum and ISPE China Conference in Hangzhou, China on 26-27, May 2023. Mr. Ping Zhang, Chairman of SPIC and the ISPE China Committee, introduced ISPE and provided an in-depth analysis of the prospects of domestic and foreign bio-pharmaceutical enterprises. The in-depth discussions from this...
Facility of the Year Award (FOYA) Winners in the Innovation category exemplify the application of novel manufacturing processes, innovative design concepts, new technologies, and unique solutions that...